ETR:SBS Stratec (SBS) Stock Price, News & Analysis → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free SBS Stock Alerts €40.20 -2.20 (-5.19%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range€37.50▼€40.9550-Day Range€40.50▼€44.9552-Week Range€36.00▼€69.00Volume46,140 shsAverage Volume6,253 shsMarket Capitalization$488.83 millionP/E Ratio40.61Dividend Yield2.41%Price Target€79.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesStock AnalysisAnalyst ForecastsChartHeadlines Get Stratec alerts: Email Address Stratec MarketRank™ Stock AnalysisAnalyst Rating0.00 Rating ScoreUpside/Downside96.5% Upside€79.00 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment-0.29Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.03 out of 5 stars 2.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of €79.00, Stratec has a forecasted upside of 96.5% from its current price of €40.20.Amount of Analyst CoverageStratec has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for SBS. Previous Next 0.8 Dividend Strength Dividend YieldStratec pays a meaningful dividend of 2.30%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthStratec does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Stratec is 97.98%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SBS. Previous Next 1.5 News and Social Media Coverage News SentimentStratec has a news sentiment score of -0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Stratec this week, compared to 0 articles on an average week.Search Interest1 people have searched for SBS on MarketBeat in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Stratec insiders have not sold or bought any company stock.Percentage Held by Insiders40.55% of the stock of Stratec is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions43.78% of the stock of Stratec is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Stratec is 40.61, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 145.42.Price to Earnings Ratio vs. SectorThe P/E ratio of Stratec is 40.61, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 250.30.Price to Earnings Growth RatioStratec has a PEG Ratio of 10.43. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioStratec has a P/B Ratio of 2.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingAI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit About Stratec Stock (ETR:SBS)Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. The company operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput segment. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.Read More SBS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SBS Stock News HeadlinesMarch 28, 2024 | markets.businessinsider.comEQS-News: STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEARMarch 28, 2024 | finance.yahoo.comStratec (ETR:SBS) Is Reducing Its Dividend To €0.55March 28, 2024 | Prosper Trading Academy (Ad)Did you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:March 26, 2024 | finance.yahoo.comStratec (ETR:SBS) shareholders have endured a 62% loss from investing in the stock three years agoMarch 16, 2024 | morningstar.comStratec SE SBSMarch 2, 2024 | finance.yahoo.comWith 48% stake, Stratec SE (ETR:SBS) seems to have captured institutional investors' interestDecember 21, 2023 | markets.businessinsider.comEQS-News: STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCENovember 21, 2023 | finance.yahoo.comStratec SE (ETR:SBS) Shares Could Be 35% Below Their Intrinsic Value EstimateMarch 28, 2024 | Prosper Trading Academy (Ad)Did you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:November 7, 2023 | finance.yahoo.comDeclining Stock and Decent Financials: Is The Market Wrong About Stratec SE (ETR:SBS)?October 28, 2023 | markets.businessinsider.comEQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023October 24, 2023 | finance.yahoo.comStratec's (ETR:SBS) Returns Have Hit A WallOctober 10, 2023 | finance.yahoo.comStratec (ETR:SBS) investors are sitting on a loss of 65% if they invested three years agoSeptember 24, 2023 | finance.yahoo.comWith 42% stake, Stratec SE (ETR:SBS) seems to have captured institutional investors' interestAugust 9, 2023 | markets.businessinsider.comEQS-News: STRATEC POSTS FINAL RESULTS FOR FIRST HALF OF 2023July 4, 2023 | uk.movies.yahoo.comSTRATEC COMPLETES ACQUISITION OF NATECH PLASTICSJune 14, 2023 | finance.yahoo.comIs Stratec SE (ETR:SBS) Trading At A 37% Discount?June 9, 2023 | msn.comHAUCK AUFHAEUSER INVESTMENT BANKING Maintains STRATEC SE (FWB:SBS) Buy RecommendationJune 8, 2023 | msn.comSRH ALSTERRESEARCH AG Maintains STRATEC SE (FWB:SBS) Hold RecommendationJune 7, 2023 | finance.yahoo.comSTRATEC SE: STRATEC Further Expands Its Presence in USA By Acquiring Natech PlasticsJune 7, 2023 | markets.businessinsider.comEQS-News: STRATEC SE: STRATEC FURTHER EXPANDS ITS PRESENCE IN USA BY ACQUIRING NATECH PLASTICSMay 31, 2023 | finance.yahoo.comWill Weakness in Stratec SE's (ETR:SBS) Stock Prove Temporary Given Strong Fundamentals?May 17, 2023 | markets.businessinsider.comEQS-News: STRATECS ANNUAL GENERAL MEETING APPROVES FURTHER DIVIDEND INCREASE: DISTRIBUTION RISES TO 0.97 PER SHAREMay 17, 2023 | finance.yahoo.comReturns On Capital At Stratec (ETR:SBS) Have Hit The BrakesMay 3, 2023 | finance.yahoo.comInvestors in Stratec (ETR:SBS) have unfortunately lost 42% over the last yearApril 28, 2023 | markets.businessinsider.comEQS-News: STRATEC POSTS RESULTS FOR FIRST QUARTER OF 2023 AND CONFIRMS FINANCIAL GUIDANCEApril 22, 2023 | msn.comBERENBERG Maintains STRATEC SE (FWB:SBS) Hold RecommendationSee More Headlines Receive SBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stratec and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolETR:SBS CUSIPN/A CIKN/A Webwww.stratec.com Phone+49-7082-79160FaxN/AEmployees1,532Year FoundedN/APrice Target and Rating Average Stock Price Target€79.00 High Stock Price Target€87.00 Low Stock Price Target€71.00 Potential Upside/Downside+86.3%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)€0.99 Trailing P/E Ratio42.83 Forward P/E Ratio11.78 P/E Growth10.43Net Income$12.03 million Net Margins4.72% Pretax MarginN/A Return on Equity5.46% Return on Assets3.12% Debt Debt-to-Equity Ratio42.12 Current Ratio2.28 Quick Ratio1.65 Sales & Book Value Annual Sales$254.65 million Price / Sales2.02 Cash Flow€1.78 per share Price / Cash Flow23.85 Book Value€18.58 per share Price / Book2.28Miscellaneous Outstanding Shares12,160,000Free FloatN/AMarket Cap$515.58 million OptionableNot Optionable Beta0.14 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Marcus Wolfinger (Age 57)Chairman of Board of Management & CEO Comp: $1.13MDr. Robert Siegle (Age 57)Director of Finance & Human Resources and Member of Board of Management Comp: $914kDr. Claus Vielsack (Age 57)Director of Product Development & Member of Board of Management Comp: $710kMr. Hermann Leistner (Age 78)Founder & Advisor Dr. Georg Bauer (Age 51)Member of Management Board Mr. Jan KeppelerHead of Investor Relations, Sustainability & Corporate CommunicationsMr. Roland UtzHead of Supply Chain Management & Senior VPMore ExecutivesKey CompetitorsDrägerwerk AG & Co. KGaAETR:DRW3RHÖN-KLINIKUM AktiengesellschaftETR:RHKBiotest AktiengesellschaftETR:BIOCompuGroup Medical SE & Co. KGaAETR:COPShop Apotheke EuropeETR:SAEView All Competitors SBS Stock Analysis - Frequently Asked Questions What is Stratec's stock price target for 2024? 0 analysts have issued 1-year price objectives for Stratec's shares. Their SBS share price targets range from €71.00 to €87.00. On average, they predict the company's stock price to reach €79.00 in the next twelve months. This suggests a possible upside of 96.5% from the stock's current price. View analysts price targets for SBS or view top-rated stocks among Wall Street analysts. How have SBS shares performed in 2024? Stratec's stock was trading at €45.55 at the beginning of 2024. Since then, SBS shares have decreased by 11.7% and is now trading at €40.20. View the best growth stocks for 2024 here. Is Stratec a good dividend stock? Stratec (ETR:SBS) pays an annual dividend of €0.97 per share and currently has a dividend yield of 2.30%. The dividend payout ratio is 97.98%. Payout ratios above 75% are not desirable because they may not be sustainable. What other stocks do shareholders of Stratec own? Based on aggregate information from My MarketBeat watchlists, some companies that other Stratec investors own include Great Portland Estates (GPOR), Gogo (GOGO), Depomed (DEPO), Cenovus Energy (CVE), China Hydroelectric Corp Foreign (CHC), Bio-Rad Laboratories (BIO), Berkshire Hills Bancorp (BHLB), ASGN (ASGN), Apptio (APTI) and Anadarko Petroleum (APC). This page (ETR:SBS) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stratec SE Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.